The reduction in the risk of nonvertebral fracture did not reach statistical significance (42 versus 55 per 1000 persons; RR 0.79, 95% CI 0.47–1.33).
← all excerpts
Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective.
1
—
—